Who is sponsoring NCT06858943?

NCT06858943 is sponsored by Cairo University.

What drugs are being tested in NCT06858943?

Interventions in NCT06858943: arthroscopic meniscus reconstruction using a tendon autograft.

What condition does NCT06858943 study?

NCT06858943 studies Meniscectomy.

Is NCT06858943 still recruiting?

NCT06858943 is currently completed. Last updated 11 March 2025.

Last reviewed 2025-03-11 · How we verify

NCT06858943: DR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Can Tendon Autograft Function As a Meniscal Transplant

Completed NA Last updated 11 March 2025

What this trial tests

NA trial testing arthroscopic meniscus reconstruction using a tendon autograft in Meniscectomy in 25 participants. Completed in 31 December 2024.

Timeline

1 May 2022

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	25
Start date	1 May 2022
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across Egypt

Drugs / interventions tested

arthroscopic meniscus reconstruction using a tendon autograft

Conditions studied

Meniscectomy — all drugs for Meniscectomy →

Sponsor

Cairo University

Who can join

Adults 22 to 40, any sex, with Meniscectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: To evaluate the functional outcomes after using peroneus longus (PL) tendon autograft as meniscal transplantation in patients with knee joint line pain exaggerated with weight bearing following prior total or subtotal meniscectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06858943 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 11 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06858943.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing